Patent · US Active

Inhibition of the renin-angiotensin system for the treatment of renal, vascular and cartilage pathology

US8765678B2 · kind B2 · utility

1Cited by

1References

7Claims

0Family size

Assignee

MOR RESEARCH APPLICATIONS LTD. · IL

Inventors

Talia Weinstein · Nes Ziona, IL
Uzi Gafter · Netanya, IL
Zvi Nevo · Herzliya, IL
Dror Robinson · Modiin-Maccabim-Reut, IL
Zoharia Evron · Hod HaSharon, IL

Key dates

Filing date	Jul 27, 2006
Grant date	Jul 1, 2014
Priority date	—
Expiry date	Aug 1, 2029

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10T436/143333
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method of treating a disease or condition in which up-regulating GAGs is therapeutically beneficial is disclosed, in particular osteoarthritis and skin diseases. The method comprises locally administering to a subject a therapeutically effective amount of an agent capable of down-regulating activity or expression of a component of the renin-angiotensin system.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.